MedTech
Our innovation extends beyond radiopharmaceuticals. Through MedTech, we develop advanced technologies, including radioguided surgery, personalized dosimetry, and AI-powered imaging tools, that enhance the precision and impact of cancer care.
Core innovation pillars
Radioguided surgery
We are advancing radioguided surgery with SENSEI® — a miniature drop-in robotic gamma probe that enables surgeons to detect and remove cancerous tissue in real-time, when used with our precision diagnostics.
Personalized dosimetry
QDOSE® is a validated, clinician-facing dosimetry platform that helps doctors measure and personalize radiation doses for each patient. By analyzing medical images and calculating how radiation is absorbed in tumors and healthy organs, QDOSE supports safer, more effective theranostic treatments tailored to individual needs.
AI
Our AI-driven tools help physicians better understand molecular imaging and guide treatment decisions. Through automated segmentation, image analysis, and dosimetry modeling, we aim to support more precise and personalized care for patients.
Partnering and collaboration
We collaborate with physicians, academic centers, and industry partners to advance next-generation theranostic technologies. Integrating scientific innovation with frontline clinical experience enables us to address real-world challenges and enhance patient outcomes.